{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T04:26:04Z","timestamp":1730348764032,"version":"3.28.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,30]]},"DOI":"10.7759\/cureus.72696","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T12:34:34Z","timestamp":1730291674000},"source":"Crossref","is-referenced-by-count":0,"title":["Stent Graft Restenosis: Insights From Optical Coherence Tomography Imaging and Treatment Considerations"],"prefix":"10.7759","author":[{"given":"Hiroshi","family":"Abe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Isogai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Tokano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Minamino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC Guidelines for the management of peripheral arterial and aortic diseases","volume":"45","author":"Mazzolai L","year":"2024","unstructured":"Mazzolai L, Teixido-Tura G, Lanzi S, et al.. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J. 2024, 45:3538-700. 10.1093\/eurheartj\/ehae179","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.10.036","article-title":"Revascularization strategies for patients\u00a0with femoropopliteal peripheral\u00a0artery disease","volume":"81","author":"Farhan S","year":"2023","unstructured":"Farhan S, Enzmann FK, Bjorkman P, et al.. Revascularization strategies for patients\u00a0with femoropopliteal peripheral\u00a0artery disease. J Am Coll Cardiol. 2023, 81:358-70. 10.1016\/j.jacc.2022.10.036","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/1708538116658392","article-title":"Prognostic significance of ankle brachial pressure index: a systematic review and meta-analysis","volume":"25","author":"Hajibandeh S","year":"2017","unstructured":"Hajibandeh S, Hajibandeh S, Shah S, Child E, Antoniou GA, Torella F. Prognostic significance of ankle brachial pressure index: a systematic review and meta-analysis. Vascular. 2017, 25:208-24. 10.1177\/1708538116658392","journal-title":"Vascular"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2005206","article-title":"Mortality with paclitaxel-coated devices in peripheral artery disease","volume":"383","author":"Nordanstig J","year":"2020","unstructured":"Nordanstig J, James S, Andersson M, et al.. Mortality with paclitaxel-coated devices in peripheral artery disease. N Engl J Med. 2020, 383:2538-46. 10.1056\/NEJMoa2005206","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.05.079","article-title":"Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease)","volume":"62","author":"Lammer J","year":"2013","unstructured":"Lammer J, Zeller T, Hausegger KA, et al.. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). J Am Coll Cardiol. 2013, 62:1320-7. 10.1016\/j.jacc.2013.05.079","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2012.10.004","article-title":"Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial","volume":"24","author":"Saxon RR","year":"2013","unstructured":"Saxon RR, Chervu A, Jones PA, et al.. Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial. J Vasc Interv Radiol. 2013, 24:165-73; quiz 174. 10.1016\/j.jvir.2012.10.004","journal-title":"J Vasc Interv Radiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/15266028211057091","article-title":"The Effect of Aggressive Wire Recanalization in Calcified Atheroma and Dilatation (ARCADIA) technique in eccentric calcified lesion of no-stenting zone","volume":"29","author":"Konishi H","year":"2022","unstructured":"Konishi H, Koshida R, Habara M, et al.. The Effect of Aggressive Wire Recanalization in Calcified Atheroma and Dilatation (ARCADIA) technique in eccentric calcified lesion of no-stenting zone. J Endovasc Ther. 2022, 29:536-43. 10.1177\/15266028211057091","journal-title":"J Endovasc Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/1526602817719881","article-title":"Histological evaluation of a self-expanding stent-graft 23 months after implantation in the superficial femoral artery","volume":"24","author":"Ishihara T","year":"2017","unstructured":"Ishihara T, Iida O, Inoue K, et al.. Histological evaluation of a self-expanding stent-graft 23 months after implantation in the superficial femoral artery. J Endovasc Ther. 2017, 24:746-50. 10.1177\/1526602817719881","journal-title":"J Endovasc Ther"},{"key":"ref9","article-title":"Pathologic considerations in replacement heart valves and other cardiovascular prosthetic devices","volume":"37","author":"Schoen FJ","year":"1995","unstructured":"Schoen FJ. Pathologic considerations in replacement heart valves and other cardiovascular prosthetic devices. Monogr Pathol. 1995, 37:194-222.","journal-title":"Monogr Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07323.x","article-title":"Virchow and his triad: a question of attribution","volume":"143","author":"Bagot CN","year":"2008","unstructured":"Bagot CN, Arya R. Virchow and his triad: a question of attribution. Br J Haematol. 2008, 143:180-90. 10.1111\/j.1365-2141.2008.07323.x","journal-title":"Br J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/313301-stent-graft-restenosis-insights-from-optical-coherence-tomography-imaging-and-treatment-considerations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T12:34:36Z","timestamp":1730291676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/313301-stent-graft-restenosis-insights-from-optical-coherence-tomography-imaging-and-treatment-considerations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.72696","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,30]]}}}